← Open Payments lookup

ERIC CHEUNG: Open Payments

NPI 1013421973 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,247 in 92 payments from 17 companies in 2025. Trend: 2023 $2,318 · 2024 $2,131 · 2025 $2,247

Food & beverage: $2,247
CompanyPaymentsAmount
Amgen Inc.27$497
Phathom Pharmaceuticals, Inc.7$376
Bayer Healthcare Pharmaceuticals Inc.10$262
Gilead Sciences, Inc.5$208
GlaxoSmithKline, LLC.10$181
Aimmune Therapeutics, Inc.5$132
Novo Nordisk Inc5$101
IBSA Pharma Inc.5$95
Ardelyx, Inc.3$80
ABBVIE INC.3$58

Products named: VOQUEZNA, Kerendia, OTEZLA, EVENITY, TRELEGY ELLIPTA, ZENPEP, Ozempic, Tirosint.

Industry payments across CA — which companies pay providers there.